Tod Ibrahim and David White discuss the Biden administration's first 100 days, specifically the vaccine situation and regulatory issues related to kidney transplantation.

Tod Ibrahim and David White discuss the federal budget process and what that means for kidney and health care policy in the US.

Tod Ibrahim and David White discuss a new White House initiative to get kidney patients vaccinated in dialysis centers. They also discuss what's happening in the world of transplant policy.

Tod Ibrahim talks to Dr. Suzanne Watnick and Elizabeth McNamara of Northwest Kidney Centers about what they've learned since COVID-19 first hit the US last year.

Tod Ibrahim and David White update listeners on the Affordable Care Act, transplant policy, and the mandatory and voluntary payment models for nephrologists.

Tod Ibrahim and David White discuss how the composition of the Senate might affect policy discussions, as well as the Biden administration's executive orders on addressing disparities in health care and society at large.

Tod Ibrahim and David White talk about what could happen for kidney care and health care in 2021.

Tod Ibrahim and David White talk about the end-of-year stimulus package from Congress and the recent approval of full immunosuppressive drug coverage for kidney transplant recipients.

Tod Ibrahim and David White discuss what the health care team will look like in a Biden-Harris administration.

Tod Ibrahim and David White review what the federal government is doing to promote awareness of kidney diseases, improve treatment options, and fund research, discovery, and innovation.